Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Radiation × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 14 Glioblastoma 13 Breast Neoplasms 13 Oropharyngeal Neoplasms 11 Lung Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 6 Glioma 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Mouth Neoplasms 5 Sarcoma 4 Laryngeal Neoplasms 4 Histiocytoma, Malignant Fibrous 4 Ganglioneuroblastoma 4 Carcinoma, Squamous Cell 4 Carcinoma 4 Astrocytoma 4 Sarcoma, Ewing 3 Rhabdomyosarcoma, Embryonal 3 Rhabdomyosarcoma 3 Pancreatic Neoplasms 3 Neuroblastoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Liposarcoma 3 Leiomyosarcoma 3 Gliosarcoma 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3

Interventions

pembrolizumab 27 enfortumab vedotin 16 Nivolumab 14 Gemcitabine 12 avelumab 10 Magnetic Resonance Spectroscopy 10 Cisplatin 10 Carboplatin 10 Specimen Handling 9 sacituzumab govitecan 6 atezolizumab 6 durvalumab 5 Ipilimumab 5 Docetaxel 5 Paclitaxel 4 cabozantinib 3 Taxes 3 tislelizumab 2 relatlimab 2 lenvatinib 2 erdafitinib 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Cryosurgery 2 CTLA-4 Antigen 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡